Oxandrolone in pediatric patients with severe thermal burn injury

Annals of Pharmacotherapy

Volumn 42, Issue 9, 2008, Pages 1310-1315

  Miller, James T ^a,b,c   Btaiche, Imad F ^a,b  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c SINAI GRACE HOSPITAL   (United States)

Author keywords

Burns; Children; Oxandrolone

Indexed keywords

ANDROGEN RECEPTOR; LIOTHYRONINE; OXANDROLONE; PLACEBO; SERUM ALBUMIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACNE; AMINOTRANSFERASE BLOOD LEVEL; BEHAVIOR CHANGE; BONE MINERAL; BURN; CHILD CARE; CLINICAL TRIAL; CLITORIS; CLITORIS HOOD REDUNDANCY; CLITORIS HYPERTROPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; EPIPHYSIS DISEASE; EXERCISE; HIRSUTISM; HORMONAL REGULATION; HUMAN; LEAN BODY WEIGHT; MUSCLE STRENGTH; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; REVIEW; SEPSIS; SIDE EFFECT; VIRILIZATION; VULVA DISEASE; WEIGHT GAIN;

ANABOLIC AGENTS; BURNS; CHILD; HUMANS; METABOLIC DISEASES; OXANDROLONE;

EID: 50249164687     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L162     Document Type: Review

References (26)

1. Lee JO, Benjamin D, Herndon DN. Nutrition support strategies for severely burned patients. Nutr Clin Pract 2005;20:325-30.
2. Shea JE, Bowman BM, Miller SC. Alterations in skeletal and mineral metabolism following thermal injuries. J Musculoskelet Neuronal Interact 2003;3:214-22.
3. Jeschke MG, Mlcak RP, Finnerty CC, et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care 2007;11:R90. DOI 10.1186/cc6102
4. Przkora R, Herndon DN, Jeschke MG. The factor age and the recovery of severely burned children. Burns 2008;34:41-4.
5. Jeschke MG, Barrow RE, Mlcak RP, Herndon DN. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg 2005;241:759-67.
6. Hart DW, Wolf SE, Chinkes DL, et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma 2003;54:755-61.
7. Mochizuki H, Trocki O, Dominioni L, Brackett KA, Joffe SN, Alexander JW. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding. Ann Surg 1984;200:297-310.
8. Venter M, Rode H, Sive A, Vesser M. Enteral resuscitation and early enteral feeding in children with major burns. Effect on McFarlane response to stress. Burns 2007;33:464-71.
9. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990;212:424-9.
10. Gore DC, Honeycutt D, Jahoor F, Rutan T, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on glucose utilization in burn patients. J Surg Res 1991;51:518-23.
11. Hart DW, Herndon DN, Klein G, et al. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg 2001;233:827-34.
12. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999;229:11-8.
13. Cochran A, Davis L, Morris SE, Saffle JR. Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit. J Burn Care Res 2008;29:187-91.
14. Ferrando AA, Sheffield-Moore M, Wolf SE, Herndon DN, Wolfe RR. Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med 2001;29:1936-42.
15. Package insert. Oxandrin (oxandrolone tablets, USP, CIII). East Brunswick, NJ: Savient Pharmaceuticals, Inc., January 2006.
16. Saggers GC, Allison BS, Levinson HD, Kramer MD, Mackay DR, Ehrlich HP. The influence of the anabolic agent oxandrolone upon the expression of procollagen types I and III mRNA in human fibroblasts cultured on collagen or plastic. Wounds 2001;13:66-71.
17. Lacy CF, Armstrong LL, Goldman MP, Lance LL, eds. Oxandrolone. In: Drug information handbook. 15th ed. Hudson, OH: Lexi-Comp Inc., 2007:1278-9.
18. Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 2001;233:556-64.
19. Barrow RE, Dasu MR, Ferrando AA, et al. Gene expression patterns in skeletal muscle of thermally injured children treated with oxandrolone. Ann Surg 2003;237:422-8.
20. Wolf SE, Thomas SJ, Dasu MR, et al. Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned. Ann Surg 2003;237:801-10.
21. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 2007;246:351-60.
22. Thomas S, Wolf SE, Murphy KD, Chinkes DL, Herndon DN. The long-term effect of oxandrolone on hepatic acute phase proteins in severely burned children. J Trauma 2004;56:37-44.
23. Murphy KD, Thomas S, Mlcak RP, Chinkes DL, Klein GL, Herndon DN. Effects of long-term oxandrolone administration in severely burned children. Surgery 2004;136:219-24.
24. Przkora R, Jeschke MG, Barrow RE, et al. Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. Ann Surg 2005;242:384-9.
25. Przkora R, Herndon DN, Suman OE. The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. Pediatrics 2007;119:e109-e116.
26. Red Book. Montvale, NJ: Thomson Healthcare, 2008:529-30.